bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Nektar Therapeutics logo

    Nektar Therapeutics

    NKTR | NASDAQ
    Chart Builder DCF Calculator
    $66.84
    -$0.26 (-0.39%)
    At close: Sep 21, 2026, 4:00 PM ET
    $66.86
    +$0.02 (+0.03%)
    Pre-market: Sep 22, 2026, 9:16 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.92B
    Enterprise Value
    $1.31B
    Beta
    1.15
    Average Volume
    872.3K
    Shares Outstanding (Diluted)
    28.92M
    Shares Change YoY
    134.64%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US6402683063

    Price Performance

    Price Change 1M
    -8.4%
    Price Change 3M
    0.2%
    Price Change 6M
    -7.3%
    Price Change YTD
    53.9%
    Price Change 1Y
    13.5%
    Price Change 3Y
    624.2%
    Price Change 5Y
    -75.9%
    1M CAGR (ann.)
    -12.6%
    1Y CAGR (ann.)
    13.8%
    5Y CAGR (ann.)
    -22.9%
    All-Time CAGR
    -5.6%

    Valuation

    PE Ratio
    -10.11
    Forward PE
    N/A
    PEG Ratio
    -1.04
    Forward PEG
    -0.35
    PS Ratio
    35.13
    Forward PS
    33.60
    PB Ratio
    2.12
    P/FCF Ratio
    -8.19
    P/Adj. FCF Ratio
    -7.79
    P/OCF Ratio
    -9.45
    EV/Sales
    24.03
    EV/EBIT
    -14.15
    EV/EBITDA
    -9.75
    EV/FCF
    -5.60
    Earnings Yield
    -9.9%
    FCF Yield
    -12.2%
    Adj. FCF Yield
    -12.8%

    Financial Health

    Net Cash
    $605.79M
    Total Debt
    $78.56M
    Cash & Short-Term Investments
    $684.34M
    Total Assets
    $1.1B
    Current Ratio
    10.42
    Quick Ratio
    10.42
    Debt / Equity Ratio
    0.15
    Debt / EBITDA
    -0.58
    Debt / FCF
    -0.34
    OCF / Debt
    -2.98
    Interest Coverage
    -4.24
    Altman Z-Score
    1.58
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    99.4%
    Operating Profit Margin
    -240.4%
    EBITDA Margin
    -246.2%
    Net Profit Margin
    -287.8%
    FCF Margin
    -428.8%
    Adj. FCF Margin
    -450.7%
    SBC / Revenue
    21.9%
    SBC Impact (per share)
    -5.1%

    Returns

    Return on Assets
    -14.3%
    Return on Equity
    -38.0%
    Return on Invested Capital
    -12.5%
    Return on Capital Employed
    -12.8%
    Return on Tangible Assets
    -14.3%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -14.6%
    Revenue CAGR 5Y
    -12.3%
    Revenue CAGR 10Y
    -11.8%
    EPS CAGR 3Y
    35.9%
    EPS CAGR 5Y
    45.6%
    EPS CAGR 10Y
    -11.5%
    FCF CAGR 3Y
    -14.8%
    FCF CAGR 5Y
    17.7%
    FCF CAGR 10Y
    -26.9%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    33
    EPS Growth Next 3Y
    -13.4%
    Revenue Growth Next 3Y
    -2.0%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$2.13
    EPS Growth Est (next Q)
    15.2%
    Revenue Est (next Q)
    $10.41M
    Revenue Growth Est (next Q)
    -11.7%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $152.50
    Price Target Upside
    128.2%

    Cash Flow

    Operating Cash Flow
    $-233.79M
    Free Cash Flow
    $-234.05M
    Adj. Free Cash Flow
    $-246.04M
    FCF Per Share
    -$7.08
    OCF Per Share
    -$7.07
    OCF/S Ratio
    -428.3%

    Income Statement

    Revenue
    $54.59M
    Gross Profit
    $33.4M
    Operating Income
    $-131.22M
    EBITDA
    $-134.49M
    Net Income
    $-157.13M
    EPS (Diluted)
    -$6.61
    Revenue / Employee
    $866.49K
    Profit / Employee
    $-2.49M
    Employees
    63

    © 2026 bestshares.com. All rights reserved.